ArticleOncoTargets and therapy2016

High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy.

Chunyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.